Dr Graham Collins

MBBS, MA, MRCP, FRCPath, DPhil

Haematology Consultant

Special clinical interests in Lymphoma, lymphoproliferative disorders

Dr Collins is currently the Lymphoma Lead for Oxford University Hospitals and he is active nationally in clinical trials and guidelines development. His interests are in lymphoproliferative disorders and together with Dr Chris Hatton, he is joint Programme Director for the national specialist trainee lymphoma management course.

Dr Collins was a member of the lymphoma guidelines development group of NICE and has co-authored the national guidelines for relapsed Hodgkin’s lymphoma.

Treatments/Procedures

Chemotherapy, drug therapy, stem cell transplantation

NHS Hospital / affiliated hospitals / current post(s)

Oxford University Hospital

Year Qualified

1999

Other clinical Interests

Development and running of clinical trials in lymphoid disorders

Research interests / Publications & Affiliations

Clinical trials of novel treatments in Diffuse large B-cell lymphoma, Hodgkin Lymphoma and T-cell lymphoma. Also active in trials in low grade lymphomas.

Professional Memberships & international or national committees

  •  Member of the Royal College of Physicians (MRCP)
  •  Fellow of the Royal College of Pathologists (FRCPath)
  •  Member of the British Society of Haematology
  •  Member of the American Society of Hematology
  •  Past member of the lymphoma guidelines development group of the National Institute for Health and Care Excellence (NICE)
  •  Chair of the UK Hodgkin Lymphoma Study group and T-cell lymphoma working group
  •  Clinical Expert on the National CAR T-cell therapy panel

Awards Received 

Beacon of Hope Award 2013 (Lymphoma Action)